https://www.selleckchem.com/pr....oducts/bay-2416964.h
57, p=0.002). No side effects due to the duloxetine were recorded in group II compared to group I. The additional complementary treatment (OPT) did not appear to give the patients with TMDs and FM any further benefit but it might improve pharmacological tolerability of the traditional medication. The additional complementary treatment (OPT) did not appear to give the patients with TMDs and FM any further benefit but it might improve pharmacological tolerability of the traditional medication. We aimed to compare gender difference on
Mi piace
Commento
Condividi
